SEC Comment Letter for Pulmatrix, Inc. (PULM) (CIK 0001574235) (PULM) — Mar 25, 2019
Pulmatrix, Inc. (PULM) (CIK 0001574235)
Date: March 25, 2019 · CIK: 0001574235 · Accession: 0000000000-19-005689
AI Filing Summary & Sentiment
File numbers found in text: 333-230395
Letter
March 25, 2019 Robert W. Clarke Chief Executive Officer Pulmatrix, Inc. 99 Hayden Avenue, Suite 390 Lexington, MA 02421 Re:Pulmatrix, Inc. Registration Statement on Form S-1 Filed March 19, 2019 File No. 333-230395 Dear Dr. Clarke: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Donald Field at 202-551-3680 with any questions. Sincerely, Division of Corporation Finance Office of Healthcare & Insurance
Show Raw Text
March 25, 2019
Robert W. Clarke
Chief Executive Officer
Pulmatrix, Inc.
99 Hayden Avenue, Suite 390
Lexington, MA 02421
Re:Pulmatrix, Inc.
Registration Statement on Form S-1
Filed March 19, 2019
File No. 333-230395
Dear Dr. Clarke:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Donald Field at 202-551-3680 with any questions.
Sincerely,
Division of Corporation Finance
Office of Healthcare & Insurance